Selective high-affinity polydentate ligands and methods of making such
Abstract
This invention provides polydentate selective high affinity ligands (SHALs) that can be used in a variety of applications in a manner analogous to the use of antibodies. SHALs typically comprise a multiplicity of ligands that each binds different regions on the target molecule. The ligands are joined directly or through a linker thereby forming a polydentate moiety that typically binds the target molecule with high selectivity and avidity.
- Inventors:
- Issue Date:
- Research Org.:
- Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1093436
- Patent Number(s):
- 8536133
- Application Number:
- 12/642,684
- Assignee:
- Lawrence Livermore National Security, LLC. (Livermore, CA); The Regents of the University of California (Oakland, CA)
- Patent Classifications (CPCs):
-
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
G - PHYSICS G01 - MEASURING G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- DOE Contract Number:
- W-7405-ENG-48
- Resource Type:
- Patent
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 59 BASIC BIOLOGICAL SCIENCES
Citation Formats
DeNardo, Sally, DeNardo, Gerald, and Balhorn, Rodney. Selective high-affinity polydentate ligands and methods of making such. United States: N. p., 2013.
Web.
DeNardo, Sally, DeNardo, Gerald, & Balhorn, Rodney. Selective high-affinity polydentate ligands and methods of making such. United States.
DeNardo, Sally, DeNardo, Gerald, and Balhorn, Rodney. Tue .
"Selective high-affinity polydentate ligands and methods of making such". United States. https://www.osti.gov/servlets/purl/1093436.
@article{osti_1093436,
title = {Selective high-affinity polydentate ligands and methods of making such},
author = {DeNardo, Sally and DeNardo, Gerald and Balhorn, Rodney},
abstractNote = {This invention provides polydentate selective high affinity ligands (SHALs) that can be used in a variety of applications in a manner analogous to the use of antibodies. SHALs typically comprise a multiplicity of ligands that each binds different regions on the target molecule. The ligands are joined directly or through a linker thereby forming a polydentate moiety that typically binds the target molecule with high selectivity and avidity.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2013},
month = {9}
}
Works referenced in this record:
Spanning binding sites on allosteric proteins with polymer-linked ligand dimers
journal, October 1998
- Kramer, Richard H.; Karpen, Jeffrey W.
- Nature, Vol. 395, Issue 6703, p. 710-713
Discovering High-Affinity Ligands for Proteins: SAR by NMR
journal, November 1996
- Shuker, S. B.; Hajduk, P. J.; Meadows, R. P.
- Science, Vol. 274, Issue 5292, p. 1531-1534
Bispecific antibodies for inducing apoptosis of tumor and diseased cells
patent-application, April 2005
- Hsing-Chang, Chien; Goldenberg, David M.; Hansen, Hans J.
- US Patent Application 10/913509; 20050079184
Tumor localization and therapy with labeled antibodies to cell surface antigens
patent, April 1984
- Goldenberg, Milton D.
- US Patent Document 4,444,744
Antigenic epitopes with LYM-1 reactivity and uses thereof
patent, April 2001
- Rose, Larry M.; Meares, Claude F.; O'Donnell, Robert
- US Patent Document 6,217,871
Methods for improved targeting of antibody, antibody fragments, hormones and other targeting agents, and conjugates thereof
patent, July 1991
- Abrams, Paul G.; Schroff, Robert W.; Morgan, Jr., Alton C.
- US Patent Document 5,034,223
Nanomolecular HLA-DR10 Antibody Mimics: A Potent System for Molecular Targeted Therapy and Imaging
journal, December 2008
- DeNardo, Gerald L.; Natarajan, Arutselvan; Hok, Saphon
- Cancer Biotherapy and Radiopharmaceuticals, Vol. 23, Issue 6, p. 783-795
Process for the production of hetero-bispecific antibodies
patent, May 2000
- Lenz, Helmut; Weidle, Ulrich
- US Patent Document 6,060,285
Structure-based hepatitis c virus drug design
patent-application, September 2003
- Bolognesi, Martino; Grandi, Guido
- US Patent Application 10/312490; 20030176662
Bispecific antibodies for selective immune regulation and for selective immune cell binding
patent, February 1997
- Wong, Johnson; Colvin, Robert
- US Patent Document 5,601,819
Pharmacokinetic Characterization in Xenografted Mice of a Series of First-Generation Mimics for HLA-DR Antibody, Lym-1, as Carrier Molecules to Image and Treat Lymphoma
journal, August 2007
- DeNardo, G. L.; Natarajan, A.; Hok, S.
- Journal of Nuclear Medicine, Vol. 48, Issue 8, p. 1338-1347
Bispecific antibodies that bind to vegf receptors
patent-application, December 2004
- Zhu, Zhenping
- US Patent Application 10/482630; 20040242851
Antibody heteroconjugates and bispecific antibodies for use in regulation of lymphocyte activity
patent, January 2000
- Ledbetter, Jeffrey A.; Gilliland, Lisa Kim
- US Patent Document 6,010,902
Characteristics of dimeric (bis) bidentate selective high affinity ligands as HLA-DR10 beta antibody mimics targeting non-Hodgkin's lymphoma
journal, October 2007
- DeNardo, Gerald; Hok, Saphon; Natarajan, Arutselvan
- International Journal of Oncology, Vol. 31, Issue 4, p. 729-740
Bispecific antibodies that bind TRAIL-R1 and TRAIL-R2
patent-application, October 2002
- Lynch, David H.
- US Patent Application 09/839632; 20020155109
Bispecific antibodies
patent-application, June 2005
- Kufer, Peter; Berry, Meera; Baeuerle, Patrick
- US Patent Application 10/743697; 20050136050
Disruption of Anthrax Toxin Binding with the Use of Human Antibodies and Competitive Inhibitors
journal, June 1999
- Cirino, Nick M.; Sblattero, Daniele; Allen, David
- Infection and Immunity, Vol. 67, Issue 6
Radioimmunotherapy of lymphoma using anti-CD20
patent, January 1997
- Kaminski, Mark S.; Butchko, Gregory M.; Glenn, Stephan D.
- US Patent Document 5,595,721
Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes
patent-application, May 2001
- Weiner, George J.; Rokhlin, Oska W.; Cohen, Michael B.
- US Patent Application 09/757336; 20010001310
Structure-Based Design of a Bispecific Receptor Mimic That Inhibits T Cell Responses to a Superantigen
journal, April 2001
- Lehnert, Nancy M.; Allen, David L.; Allen, Beth L.
- Biochemistry, Vol. 40, Issue 14, p. 4222-4228
Lead discovery using molecular docking
journal, August 2002
- Shoichet, Brian K.; McGovern, Susan L.; Wei, Binqing
- Current Opinion in Chemical Biology, Vol. 6, Issue 4, p. 439-446
Update: Systemic Radiotherapy Can Cure Lymphoma: A Paradigm for Other Malignancies?
journal, August 2008
- Denardo, Gerald L.; Denardo, Sally J.; Balhorn, Rod
- Cancer Biotherapy and Radiopharmaceuticals, Vol. 23, Issue 4, p. 383-398
AB5 toxins: structures and inhibitor design
journal, December 2000
- Fan, Erkang; Merritt, Ethan A.; Verlinde, Christophe L. M. J.
- Current Opinion in Structural Biology, Vol. 10, Issue 6, p. 680-686
Synthesis and Radiolabeling of Selective High-Affinity Ligands Designed to Target Non-Hodgkin's Lymphoma and Leukemia
journal, May 2007
- Hok, Saphon; Natarajan, Arutselvan; Balhorn, Rod
- Bioconjugate Chemistry, Vol. 18, Issue 3, p. 912-921
Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
patent, November 1982
- Goldenberg, Milton D.
- US Patent Document 4,361,544
Direct Antilymphoma Activity of Novel, First-Generation "Antibody Mimics" that Bind HLA-DR10-Positive Non-Hodgkin's Lymphoma Cells
journal, December 2006
- West, Jeremy; Perkins, Julie; Hok, Saphon
- Cancer Biotherapy and Radiopharmaceuticals, Vol. 21, Issue 6, p. 645-654
Bispecific antibodies, methods of production and uses thereof
patent, September 1999
- Ring, David B.; Shi, Tian
- US Patent Document 5,959,084
Destruction of contaminating tumor cells in stem cell transplants using bispecific antibodies
patent, November 1999
- Lindhofer, Horst; Menzel, Helge; Kolb, Hans-Jochem
- US Patent Document 5,985,276
Use of bispecific antibodies to regulate immune responses
patent-application, April 2003
- Bigler, Michael Eric; Cherwinski, Holly Marie; Phillips, Joseph H.
- US Patent Application 10/270084; 20030077282
Destruction of contaminating tumor cells in stem cell transplants using bispecific antibodies
patent, April 2001
- Lindhofer, Horst; Menzel, Helge; Kolb, Hans-Jochem
- US Patent Document 6,210,668
Humanization and characterization of the anti-HLA-DR antibody 1D10
journal, January 2001
- Kostelny, Sheri A.; Link, Brian K.; Tso, J. Yun
- International Journal of Cancer, Vol. 93, Issue 4, p. 556-565
Identification of Novel Small Molecules That Bind to Two Different Sites on the Surface of Tetanus Toxin C Fragment
journal, October 2002
- Cosman, Monique; Lightstone, Felice C.; Krishnan, V. V.
- Chemical Research in Toxicology, Vol. 15, Issue 10, p. 1218-1228
Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
patent, May 1982
- Goldenberg, Milton D.
- US Patent Document 4,331,647
Bispecific antibodies, methods of production and use thereof
patent, August 2000
- Ring, David B.; Shi, Tian
- US Patent Document 6,106,833
Hexa-arginine enhanced uptake and residualization of selective high affinity ligands by Raji lymphoma cells
journal, January 2009
- Balhorn, Rod; Hok, Saphon; DeNardo, Sally
- Molecular Cancer, Vol. 8, Article No. 25
Method of enhancing the biodistribution of antibody for localization in lesions
patent, May 1990
- Beatty, John; Beatty, Barbara G.; Duda, Rosemary B.
- US Patent Document 4,921,690
Bispecific antibodies
patent-application, January 2006
- Lee, Randall J.; Larrick, James; Lum, Lawrence G.
- US Patent Application 11/170716; 20060018897